Abstracts Archive - Page 1336 of 2425 - ACR Meeting Abstracts

Abstract Number: 1957 • 2017 ACR/ARHP Annual Meeting
Impact of Maternal Systemic Autoimmune Rheumatic Diseases on Neonatal Outcomes: A Population-Level Analysis
Stephanie Keeling¹, Anamaria Savu² and Padmaja Kaul³, ¹Department of Medicine, University of Alberta, Division of Rheumatology, Edmonton, AB, Canada, ²Canadian Vigour Center, Edmonton, AB, Canada, ³Cardiology, University of Alberta, Edmonton, AB, Canada
Background/Purpose: The impact of systemic autoimmune rheumatic diseases (SARDS) on peripartum outcomes is not well described at a population level despite the potential for active…
Abstract Number: 1958 • 2017 ACR/ARHP Annual Meeting
Burden of Rheumatic Disease Among Korean Women in Childbearing Years Based on the National Health Insurance Service-National Sample Cohort
Min Kyung Chung¹, Jisoo Lee¹, Eun-Hee Ha² and Ji-Young Shin², ¹Division of Rheumatology, Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea, Republic of (South), ²Department of Occupational and Environmental Medicine, Ewha Womans University School of Medicine, Seoul, Korea, Republic of (South)
Background/Purpose: Many rheumatic diseases predominantly affect women in their reproductive years, and have a significant impact on childbearing, but its burden remains incompletely understood. The…
Abstract Number: 1959 • 2017 ACR/ARHP Annual Meeting
Multimorbidity in Patients with Sarcoidosis: A Population-Based Cohort Study
Patompong Ungprasert¹, Eric L. Matteson² and Cynthia S. Crowson³, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, ³Department of Medicine, Division of Rheumatology,Mayo Clinic, Rochester, MN
Multimorbidity in Patients with Sarcoidosis: A Population-Based Cohort StudyBackground/Purpose: Recent studies have suggested an increased risk of comorbidity in patients with sarcoidosis. However, whether…
Abstract Number: 1960 • 2017 ACR/ARHP Annual Meeting
National Survey of Childhood-Onset Rheumatic Diseases Followed up in the Clinical Pediatric Facilities in Japan
Masaaki Mori¹, Syuji Takei², Yasuhiko Itoh³, Ichiro Kobayashi⁴, Minako Tomiita⁵, Nami Okamoto⁶ and Kazuko Yamazaki⁷, ¹Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, ²Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan, ³Department of Pediatrics, Nippon Medical School, Tokyo, Japan, ⁴Department of Allergy and Rheumatology, Chiba Children’s Hospital, Sapporo, Japan, ⁵Department of Allergy and Rheumatology, Chiba Children's Hospital, Chiba, Japan, ⁶Pediatrics, Graduate School of Medicine, Osaka Medical College, Takatsuki, Japan, ⁷Department of Pediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan
Background/Purpose: We did not grasp how many and where pediatric rheumatic patients exist in Japan quite exactly until now. About juvenile idiopathic arthritis (JIA), child-onset…
Abstract Number: 1961 • 2017 ACR/ARHP Annual Meeting
Risk Factors for Low Muscle MASS in Community-Dwelling Older Women: A Population-Based Prospective Cohort Study in Brazil. the São Paulo Ageing & Health Study
Ketty Machado¹, Diogo S Domiciano², Luana G Machado³, Jaqueline B Lopes⁴, Camille P Figueiredo⁵, Valéria F. Caparbo³, Liliam Takayama³, Paulo Menezes⁶ and Rosa M R Pereira², ¹Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ²Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil, ³Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ⁴Rheumatology Division, Rheumatology Division, Faculdade de Medicina da USP, São Paulo, Brazil, ⁵Rheumatology Division, Faculdade de Medicina da USP, São Paulo, Brazil, ⁶Preventive medicine, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Background/Purpose: Sarcopenia is a syndrome characterized by progressive loss of skeletal muscle mass, which results in decreased muscle strength and impairment of functional capacity. Moreover,…
Abstract Number: 1962 • 2017 ACR/ARHP Annual Meeting
Rates of Malignancy Associated with Anti-TNF Agents and Subsequent Biologic Use after Malignancy Using U.S. SEER Registry Data
Huifeng Yun¹, Fenglong Xie², Shuo Yang², Lang Chen¹ and Jeffrey R. Curtis³, ¹University of Alabama at Birmingham, Birmingham, AL, ²Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Biologic disease-modifying anti-rheumatic drugs (DMARDs) have been widely used for treatment of rheumatoid arthritis (RA) in United States. However, it is not clear whether…
Abstract Number: 1963 • 2017 ACR/ARHP Annual Meeting
Association of Corticosteroid Exposure with Ophthalmologic Complications and Systemic Adverse Events in Non-Infectious Uveitis Patients Using Administrative Claims in the United States
Nisha Acharya¹, Keith A. Betts², Oscar Patterson-Lomba², Arijit Ganguli³, Sophie Schonfeld² and Jenny Griffith³, ¹University of California San Francisco, San Francisco, CA, ²Analysis Group, Inc., Boston, MA, ³AbbVie Inc., North Chicago, IL
Background/Purpose: Noninfectious uveitis (NIU) is a collection of intraocular inflammatory disorders associated with significant visual impairment. Corticosteroids (CS) are typically the first-line drug therapy for…
Abstract Number: 1964 • 2017 ACR/ARHP Annual Meeting
The Risk of Hydroxychloroquine Toxic Retinopathy and Its Risk Factors in the Treatment of Rheumatic Diseases: A Systematic Review
April Jorge¹, Sharan K. Rai² and Hyon K. Choi², ¹Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ²Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Hydroxychloroquine (HCQ) is widely used in the treatment of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and other rheumatic diseases. While generally well-tolerated and…
Abstract Number: 1965 • 2017 ACR/ARHP Annual Meeting
Evolution of Anti-Citrullinated Protein Antibodies in Post-Chikungunya Arthritis Patient in Dominican Republic
E Tejada-Reyes, I Mercedes-Núñez, Y Cruz-Rojas, E Rodríguez-Bautista, V Rosario, R Peña-Blanco, R Muñoz-Louis, T Valdez-Lorie and R Alba-Fériz, Rheumatology, Hospital Docente Padre Billini (HDPB), Santo Domingo, Dominican Republic
Background/Purpose: Chikungunya (CKV) is a disease caused by an alphavirus, transmitted by mosquitoes of the genus Aedes. Is characterized by arthralgia, myalgia, arthritis and tenosynovitis.1…
Abstract Number: 1966 • 2017 ACR/ARHP Annual Meeting
Risk of Tuberculosis in Biologic Users for Rheumatic Diseases: Results from the South African Biologics Registry
Clive Pettipher¹ and Romela Benitha², ¹Rheumatology, Private Practice, Stellenbosch, South Africa, ²Rheumatology, Private Practive, Johannesburg, South Africa
Background/Purpose: To evaluate the rate of tuberculosis (TB) in biologic users for rheumatic diseases in South Africa, a TB endemic country, the effectiveness of our…
Abstract Number: 1967 • 2017 ACR/ARHP Annual Meeting
Strongyloides Screening in Immunocompromised Immigrant Rheumatology Patients
Sahitya Mallipeddi¹, Christina Coyle² and Beverly Johnson¹, ¹Rheumatology, Albert Einstein College of Medicine, Bronx, NY, ²Infectious Diseases, Albert Einstein College of Medicine, Bronx, NY
Background/Purpose: Strongyloides Stercoralis is a helminthic infection that is usually chronic and asymptomatic and may persist undiagnosed for decades. Patients from strongyloides endemic areas (tropics…
Abstract Number: 1968 • 2017 ACR/ARHP Annual Meeting
Occurrence of Rheumatic Diseases in a National Cohort of Hospitalizations for Progressive Multifocal Leukoencephalopathy
Liudmila Kastsianok¹, Prabha Ranganathan², Seth Eisen³ and Xinliang Huang⁴, ¹Rheumatology, Washington University in Saint Louis, School of Medicine, St Louis, MO, ²Washington University in Saint Louis, School of Medicine, Saint Louis, MO, ³Internal Medicine-Rheumatology, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, ⁴Washington University in Saint Louis, School of Medicine, St Louis, MO
Background/Purpose: Progressive multifocal leukoencephalopathy (PML), a rare, usually fatal, central nervous system demyelinating disorder that occurs in immunocompromised hosts, results from reactivation of the JC…
Abstract Number: 1969 • 2017 ACR/ARHP Annual Meeting
Prevalence and Predictive Value over 16 Years of Serum Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibodies in the General Population
Elena Generali¹, Natasa Isailovic¹, Maria De Santis¹, Angela Ceribelli¹, Fausto Alborghetti², Guido Colloredo³, Luisa Porrati², Torsten Matthias⁴, Alberto Zucchi², Giacomo Maria Guidelli¹, Marta Caprioli¹ and Carlo Selmi^1,5, ¹Rheumatology and Clinical Immunology, Humanitas Research Hospital, Rozzano (MI), Italy, ²Bergamo Local Health Authority (ASL), Bergamo, Italy, ³Division of Internal Medicine, San Pietro Hospital, Ponte San Pietro (BG), Italy, ⁴Aesku.Diagnostics, Wendelsheim, Germany, ⁵BIOMETRA Department, University of Milan, Milan, Italy
Background/Purpose: The prevalence of Rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies in the general population may vary widely, as RF is present in…
Abstract Number: 1970 • 2017 ACR/ARHP Annual Meeting
The Prevalence of Rheumatoid Arthritis and Allergic Diseases and Their Association : A Study of the Korean National Health and Nutrition Examination Survey (KNHANES)
Sang Hyun Joo¹, Eun Hye Park², Joongyub Lee³ and Yeong Wook Song^2,4, ¹Division of Rheumatology, Department of Internal Medicine, Jungang Medical Foundation, Jeju, Korea, Republic of (South), ²Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South), ³Division of Clinical Epidemiology Medical Research Collaborating Center Biomedical Research Institution, Seoul National University Hospital, Seoul, Korea, Republic of (South), ⁴Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea., Seoul, Korea, Republic of (South)
Background/Purpose: Allergy and autoimmune disease are related to the immune system. It was not clear in the previous studies whether allergic disease (e.g., asthma, allergic…
Abstract Number: 1971 • 2017 ACR/ARHP Annual Meeting
Association between Genetic Variants and the Presence of Rheumatoid Arthritis-Related Autoimmunity and Progression to Classified Rheumatoid Arthritis in an at-Risk Population
Rachael Sawaya¹, Elizabeth A. Bemis¹, Ryan W. Gan², Jill M. Norris³, Jeffrey A. Sparks⁴, Elizabeth Karlson⁵, M. Kristen Demoruelle⁶, Kevin D. Deane⁷, V. Michael Holers⁸, Marie L. Feser⁷, Laurie Moss⁷, Jane H. Buckner⁹, Richard M. Keating¹⁰, Peter Gregersen¹¹, Michael Weisman¹², Ted R. Mikuls¹³ and James R. O'Dell¹⁴, ¹Epidemiology, Colorado School of Public Health, Aurora, CO, ²Colorado School of Public Health, University of Colorado Denver, Aurora, CO, ³Department of Epidemiology, Colorado School of Public Health, Aurora, CO, ⁴Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁵Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁶1775 Aurora Ct, 1775 Aurora Ct, Aurora, CO, ⁷Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, ⁸Rheumatology Division, University of Colorado School of Medicine, Aurora, CO, ⁹Benaroya Research Institute at Virginia Mason, Seattle, WA, ¹⁰Division of Rheumatology, Scripps Clinic, La Jolla, CA, ¹¹The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, ¹²Cedars-Sinai Medical Center Division of Rheumatology, Los Angeles, CA, ¹³Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, ¹⁴Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease characterized by the presence of RA-related autoantibodies prior to the development of clinical disease. While HLA-shared epitope…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].